RFG
GNOM icon

REAP Financial Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

REAP Financial Group’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150
Closed -$6.92K – 626
2023
Q4 		$6.92K Buy
+150
New +$6.12K ﹤0.01% 439

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

REAP Financial Group's GNOM Position: Q1 2024 in Review

REAP Financial Group sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2024, closing a stake of 150 shares — an estimated $6.92K sold.

REAP Financial Group first reported a position in GNOM in Q4 2023 and held it in 1 quarter. The position peaked at $6.92K in Q4 2023. 59 funds tracked by Wall St. Rank hold GNOM as of Q1 2024.

  • REAP Financial Group reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
  • REAP Financial Group sold 150 Global X Genomics & Biotechnology ETF shares in Q1 2024, an estimated $6.92K.
  • REAP Financial Group first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and held it in 1 quarter.
  • REAP Financial Group's Global X Genomics & Biotechnology ETF position peaked at $6.92K in Q4 2023.
  • 59 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2024.

Based on REAP Financial Group's 13F filing for Q1 2024, filed 27 Feb 2025.